Metraipolis › archive › dc_8bdc11ce2fdb

Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41704536
DOI
10.3389/fimmu.2025.1677013
License (as archived)
solo-consultazione
Archived
2026-11-06T08:01:02.054Z
SHA-256 of the archived text
fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650
Stable URL of this page
https://metraipolis.com/documento/dc_8bdc11ce2fdb

How to cite

Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536 — Europe PMC (en), https://europepmc.org/article/MED/41704536 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8bdc11ce2fdb (Metraipolis archive dc_8bdc11ce2fdb, sha256 fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650)
BibTeX
@misc{dc8bdc11ce2fdb,
  title = {Immunoglobulin NGS enhance residual disease detection and prognosis in pediatric Ph+ acute lymphoblastic leukemia — Europe PMC PMID:41704536},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41704536},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8bdc11ce2fdb; sha256 fba407af7b1a1a2811ef6d62b3596f4166c734789f89ce46edb0a33799d0f650},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41704536. Agents can read the archived copy with the MCP tool read_document.